Search

Search Results

• NK-Cell Receptor Repertoire in Chronic Myeloid Leukemia

  Tamara Vangelevna Chitanava, R.A. Vlasik, L.O. Khordzhasov, A. Ataman, N.S. Luchkina, A.Yu. Aronov, I.D. Matvienko, N.T. Siordiya, O.V. Kulemina, N.S. Lazorko, E.I. Sbityakova, N.A. Shnalieva, E.N. Tochenaya, J.A. Alekseeva, P.A. Butylin, S.V. Smirnov, Yu. A. Zaritskii, Yu.P. Martinova, E.G. Lomaia

  152-161

  01.04.2026

• Phase 3 Clinical Trial of 300 mg Vamotinib Directly Compared with High-Dose Imatinib in Chronic Myeloid Leukemia Patients in Chronic Phase with Failure of Standard-Dose Imatinib: Interim Analysis

  A.G. Turkina, O. Yu. Vinogradova, E.G. Lomaia, B.A. Bakirov, N.M. Kalimulina, T.V. Shelekhova, I.L. Davydkin, T.I. Pospelova, O.A. Shukhov, E.Yu. Chelysheva, V.A. Shuvaev, S. Lavana, V. Khushoo, S. Apte, T.K. Dolai, R.K. Sahoo, Germes Grigorevich Chilov

  1-13

  01.01.2026

• The Role of Somatic Mutations in Various Genes and the Issue of Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients: A Literature Review

  Elena Andreevna Kuzmina, E.Yu. Chelysheva, B.V. Biderman, A.G. Turkina

  10-20

  01.01.2025

• Treatment Outcomes with Asciminib, the First Allosteric BCR::ABL1 Tyrosine Kinase Inhibitor, in Chronic Myeloid Leukemia Patients with Multiple Resistance to Prior Therapy

  A.G. Turkina, Elena Andreevna Kuzmina

  311-320

  09.06.2023

• Asciminib in Chronic Myeloid Leukemia Patients Without Therapeutic Alternatives: Results of the MAP (Managed Access Program, NCT04360005) Trial in Russia

  A.G. Turkina, Elena Andreevna Kuzmina, E.G. Lomaia, E.V. Morozova, E.Yu. Chelysheva, O.A. Shukhov, A.N. Petrova, T.V. Chitanava, Yu.Yu. Vlasova, I.S. Nemchenko, A.V. Bykova, E.I. Sbityakova, M.A. Gurianova, N.N. Tsyba, A.V. Kokhno, E.N. Parovichnikova

  54-68

  01.01.2023

• Efficacy Predictors of the Third-Line Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Phase of Chronic Myeloid Leukemia: Results of a Multi-Center Study

  E.G. Lomaia, V.A. Shuvaev, Tamara Vangelevna Chitanava, Yu.D. Matvienko, I.S. Martynkevich, S.V. Voloshin, E.V. Efremova, E.S. Mileeva, M.S. Fominykh, A.E. Kersilova, E.V. Karyagina, N.V. Il’ina, N.V. Dorofeeva, N.V. Medvedeva, A.V. Klimovich, T.V. Shneider, S.A. Stepanova, N.F. Polezhaikovskaya, N.T. Siordiya, E.I. Sbityakova, N.S. Lazorko, E.N. Tochenaya, D.V. Motorin, N.A. Shnalieva, Yu.A. Alekseeva, D.B. Zammoeva, A.Yu. Zaritskey

  271-281

  01.07.2022

• Factors for Sustaining Molecular Remission after Discontinuation of Tyrosine Kinase Inhibitors Therapy in Chronic Myeloid Leukemia: Results of Non-Randomized Prospective Clinical Trial

  Oleg Aleksandrovich Shukhov, A.N. Petrova, E.Yu. Chelysheva, A.V. Bykova, I.S. Nemchenko, A.G. Turkina

  1-12

  01.01.2021

• Opportunities of Chronic Myeloid Leukemia Treatment with Reduced Doses of Tyrosine Kinase Inhibitors

  Margarita Anatolevna Guryanova, E.Yu. Chelysheva, A.G. Turkina

  118-128

  01.01.2021

• Clinical Experience and Perspectives of Bosutinib Use in Patients with Chronic Myeloid Leukemia

  V.A. Shuvaev, Ol’ga Yur’evna Vinogradova, I.S. Martynkevich, N.V. Novitskaya, M.S. Fominykh, S.N. Tsareva, D.I. Shikhbabaeva, M.M. Pankrashkina, M.V. Chernikov, N.N. Sharkunov, I.I. Zotova, V.Yu. Udal’eva, E.V. Motyko, S.V. Voloshin

  288-294

  01.10.2018

• Chronic Myeloid Leukemia Patient Registry in the Russian Federation: From Observational Studies to the Efficacy Evaluation in Clinical Practice

  Anna Grigor’evna Turkina, N.V. Novitskaya, A.K. Golenkov, V.A. Shuvaev, L.I. Napso, I.V. Krylova, A.M. Savrilova, G.Sh. Safuanova, A.V. Korobkin, T.Yu. Klitochenko, E.V. Burnasheva, E.V. Vasil’ev, O.M. Senderova, E.Yu. Fedorova, L.M. Yalunina, E.K. Nekhai, G.B. Kuchma, A.S. Lyamkina, N.G. Shchedrova

  390-401

  01.07.2017

• Dasatinib in First- and Second-Line Therapy of Chronic Myeloid Leukemia: Efficacy, Safety and Quality of Life

  Tat’yana Ivanovna Ionova, N.B. Bulieva, O.Yu. Vinogradova, T.A. Gritsenko, L.K. Kozlova, G.B. Kuchma, E.G. Lomaia, E.R. Machyulaitene, T.P. Nikitina, N.V. Novitskaya, A.Yu. Rodionova, E.I. Usacheva, T.V. Shneider

  206-217

  01.04.2017

• Clinical and Hematological Characteristics of Patients with Chronic Myeloid Leukemia under Present-Day Conditions: Results of the Russian Part of International Multi-Center Prospective EUTOS Population-Based CML Study

  Ol’ga Veniaminovna Lazareva, A.G. Turkina, E.Yu. Chelysheva, I.A. Tishchenko, M.A. Galaiko, O.M. Senderova, V.M. Pepelyaeva, S.V. Meresii, A.S. Luchinin, G.I. Milyutina, L.V. Gavrilova, L.B. Avdeeva, O.Yu. Vinogradova, S.M. Kulikov

  65-74

  01.01.2017

• Second Generation Tyrosine Kinase Inhibitors and Their Toxicity in Treatment of Patients in Chronic Phase of Chronic Myeloid Leukemia

  N.S. Lazorko, Elza Galaktionovna Lomaia, E.G. Romanova, E.I. Sbityakova, E.R. Machyulaitene, P.A. Butylin, A.Yu. Zaritskii

  302-308

  01.07.2015

• Secondary Hemophagocytic Syndrome in the Adult Patients. Literature Review and Authors’ Experience

  Vsevolod Gennad’evich Potapenko, N.A. Potikhonova, V.V. Baikov, M.B. Belogurova, I.A. Lisukov, A.V. Klimovich, S.V. Lapin, M.O. Ivanova, V.M. Kravtsova, E.I. Podol’tseva, N.V. Medvedeva, B.V. Afanas’ev

  169-184

  01.04.2015

• New molecular markers of CML progression

  V.A. Misyurin, A.V. Misyurin, L.A. Kesayeva, Yu.P. Finashutina, Ye.N. Misyurina, I.N. Soldatova, A.A. Krutov, N.A. Lyzhko, T.V. Akhlynina, A.Ye. Lukina, T.I. Kolosheynova, N.V. Novitskaya, Ye.G. Arshanskaya, Ye.G. Ovsyannikova, R.A. Golubenko, V.A. Lapin, T.I. Pospelova, V.A. Tumakov, A.Yu. Baryshnikov

  206-212

  01.04.2014

• Current best options for first line treatment of chronic phase chronic myeloid leukemia

  R. Hehlmann, S. Saußele

  9-15

  01.01.2014

• Genfatinib® therapy for chronic-phase chronic myeloid leukemia in routine clinical practice

  T.V. Chagorova, V.V. Yablokova, P.A. Borkina, N.A. Pryanikova

  434-438

  01.10.2013

• Quality of life and symptom profile in patients with chronic myeloid leukemia receiving dasatinib as а second-line therapy due to intolerance or resistance to imatinib

  T.I. Ionova, D.A. Fedorenko, T.P. Nikitina, K.A. Kurbatova

  166-176

  01.04.2013

• Chronic hepatitis B and hematological malignancies

  A.O. Buyeverov, P.O. Bogomolov

  210-216

  01.04.2013